|
|
|
Volumn 10, Issue 51, 2001, Pages 3-4
|
|
Medroxyprogesterone and palliative care. No impact on quality of life
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MEDROXYPROGESTERONE;
MEDROXYPROGESTERONE ACETATE;
PLACEBO;
ANOREXIA;
ARTICLE;
CANCER PALLIATIVE THERAPY;
CANCER PATIENT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG INDICATION;
EDEMA;
FRANCE;
HUMAN;
LICENCE;
QUALITY OF LIFE;
THROMBOEMBOLISM;
VEIN THROMBOSIS;
WEIGHT GAIN;
WEIGHT REDUCTION;
ANTINEOPLASTIC AGENTS, HORMONAL;
APPETITE;
APPETITE STIMULANTS;
CLINICAL TRIALS;
HUMANS;
MEDROXYPROGESTERONE;
NEOPLASMS;
PALLIATIVE CARE;
QUALITY OF LIFE;
TREATMENT OUTCOME;
WEIGHT LOSS;
|
|
EID: 0035074836
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (10)
|
